Exelon Corporation
Exelon Corporation Fundamental Analysis
Exelon Corporation (EXC) shows weak financial fundamentals with a PE ratio of 17.54, profit margin of 11.41%, and ROE of 9.87%. The company generates $24.5B in annual revenue with weak year-over-year growth of 0.00%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 22.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze EXC's fundamental strength across five key dimensions:
Efficiency Score
WeakEXC struggles to generate sufficient returns from assets.
Valuation Score
ExcellentEXC trades at attractive valuation levels.
Growth Score
WeakEXC faces weak or negative growth trends.
Financial Health Score
WeakEXC carries high financial risk with limited liquidity.
Profitability Score
WeakEXC struggles to sustain strong margins.
Key Financial Metrics
Is EXC Expensive or Cheap?
P/E Ratio
EXC trades at 17.54 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, EXC's PEG of -8.19 indicates potential undervaluation.
Price to Book
The market values Exelon Corporation at 1.69 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -0.03 times EBITDA. This is generally considered low.
How Well Does EXC Make Money?
Net Profit Margin
For every $100 in sales, Exelon Corporation keeps $11.41 as profit after all expenses.
Operating Margin
Core operations generate 21.21 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $9.87 in profit for every $100 of shareholder equity.
ROA
Exelon Corporation generates $2.37 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Exelon Corporation generates strong operating cash flow of $6.33B, reflecting robust business health.
Free Cash Flow
Exelon Corporation generates weak or negative free cash flow of $-2.30B, restricting financial flexibility.
FCF Per Share
Each share generates $-2.25 in free cash annually.
FCF Yield
EXC converts -4.64% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
17.54
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-8.19
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.69
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.03
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
1.76
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.92
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.10
vs 25 benchmark
ROA
Return on assets percentage
0.02
vs 25 benchmark
ROCE
Return on capital employed
0.05
vs 25 benchmark
How EXC Stacks Against Its Sector Peers
| Metric | EXC Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 17.54 | 19.20 | Neutral |
| ROE | 9.87% | 1033.00% | Weak |
| Net Margin | 11.41% | 9191.00% | Weak |
| Debt/Equity | 1.76 | 6.63 | Strong (Low Leverage) |
| Current Ratio | 0.92 | 1.68 | Weak Liquidity |
| ROA | 2.37% | -237.00% (disorted) | Weak |
EXC outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Exelon Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
-100.00%
Industry Style: Defensive, Dividend, Income
DecliningEPS CAGR
-100.00%
Industry Style: Defensive, Dividend, Income
DecliningFCF CAGR
-100.00%
Industry Style: Defensive, Dividend, Income
Declining